Table 1 Clinical cure and pathogen eradication rates by treatment group
From: Efficacy of telavancin for treatment of surgical site infections
| TLV SA | VAN SA | TLV MRSA | VAN MRSA | |
|---|---|---|---|---|
| Clinical cure, n (%) | 41 (85) | 33 (70) | 18 (86) | 15 (71) |
| Pathogen eradication, n (%) | 40 (83) | 30 (64) | 17 (81) | 12 (57) |